"Binnen Treant Zorggroep bundelen we de krachten van de 3 ziekenhuislocaties Scheper, Bethesda en Refaja en 17 centra voor verpleeg- en ouderenzorg."

During the past decade, Treant Zorggroep conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 3 clinical trials were completed, i.e. on average, 21.4% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 3 clinical trials were completed. i.e. 42.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Treant Zorggroep" #1 sponsor was "Boehringer Ingelheim" with 2 trials, followed by "Dutch Colorectal Cancer Group" with 2 trials sponsored, "Milestone Pharmaceuticals Inc." with 2 trials sponsored, "University Medical Center Groningen" with 2 trials sponsored and "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Treant Zorggroep" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 1 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "Amphia Hospital" with 1 trials as a collaborator and "Amsterdam UMC, location VUmc" with 1 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "Treant Zorggroep" are "Atrial Fibrillation" (2 trials), "Colorectal Cancer" (2 trials), "Heart Failure" (2 trials), "Abdominal Aortic Aneurysm" (1 trials) and "Acute Coronary Syndrome" (1 trials). Many other conditions were trialed in "Treant Zorggroep" in a lesser frequency.

Most popular intervention types in "Treant Zorggroep" are "Drug" (9 trials), "Other" (2 trials), "Behavioral" (1 trials), "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Etripamil" (2 trials), "Placebo" (2 trials), "5 000 IU of heparin" (1 trials), "5-fluorouracil" (1 trials) and "ACT guided heparinization" (1 trials). Other intervention names were less common.

The vast majority of trials in "Treant Zorggroep" are 14 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Treant Zorggroep". undefined are not yet recruiting, 8 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Treant Zorggroep, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Treant Zorggroep, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".

Treant Zorggroep has several departments that took part in Clinical trials: "Bethesda Diabetes Research Center" - 5 trials